Burning Mouth Syndrome
41
4
5
25
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.4%
1 terminated out of 41 trials
96.2%
+9.6% vs benchmark
15%
6 trials in Phase 3/4
8%
2 of 25 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 25 completed trials
Clinical Trials (41)
MucoLock™ for Treatment of Stomatitis
Reducing Patient Memory Recall in the Burning Mouth Patient Population
Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment
Burning Mouth Syndrome: Effects of Occlusal Splint Therapy
Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome
Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth Syndrome
Burning Mouth Syndrome: Symptoms and Management
The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome
Inflammatory Markers in Saliva of Patients With Burning Mouth Syndrome
Comparison Between Two Treatments for Burning Mouth
Effect to the Photobiomodulation in the Burning Mouth Syndrome
Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)
Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth Syndrome
Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome
Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
Thermography and Burning Mouth Syndrome
Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
Burning Mouth Syndrome Mouth Guard Prospective Study
Burning Mouth Syndrome - New Diagnostic Criteria and Treatment
Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome